foxo4-dri senolytic FOXO4-DRI: The Peptide That Targets Zombie Cells and Aging – Revolution Health & Wellness Molecular modelling of the FOXO4-TP53
Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect FOXO4 DRI Dosing: 1mg Senolytic Protocol (2026) FOXO4 DRI Peptide: Support Healthy Cellular Aging The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI: Kill Senescent Cells, Restore Organs (2026)
Pay in 4 interest-free payments of $7.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




